# FDA Inspection 1067917 - Biomat USA, Inc. - August 24, 2018

Source: https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/da1c277f-5574-431f-a9fe-16e39ced98a0
Source feed: FDA_Inspections

> FDA Inspection 1067917 for Biomat USA, Inc. on August 24, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1067917
- Company Name: Biomat USA, Inc.
- Inspection Date: 2018-08-24
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 945319 - 2015-08-14](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/345bde05-bf8d-42c3-9cf2-0fe6d8d1ee86)
- [FDA Inspection 809386 - 2012-11-28](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/0779f0fa-8ab8-4392-b3b4-b9faf511e79f)
- [FDA Inspection 727137 - 2011-05-18](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/c591ddfc-5111-4b20-bd90-fa4d9889a65d)

Company: https://www.globalkeysolutions.net/companies/biomat-usa-inc/b98ff1e5-8848-4121-8752-7b4a313455e6

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d